Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Lars Andreas Akslen"'
Autor:
Stian Tornaas, Dimitrios Kleftogiannis, Siren Fromreide, Hilde Ytre-Hauge Smeland, Hans Jørgen Aarstad, Olav Karsten Vintermyr, Lars Andreas Akslen, Daniela Elena Costea, Harsh Nitin Dongre
Publikováno v:
Heliyon, Vol 10, Iss 10, Pp e31191- (2024)
To decipher the interactions between various components of the tumor microenvironment (TME) and tumor cells in a preserved spatial context, a multiparametric approach is essential. In this pursuit, imaging mass cytometry (IMC) emerges as a valuable t
Externí odkaz:
https://doaj.org/article/6344f46aeae6447b80fe879f9f1b0eb1
Autor:
Lars Andreas Akslen, Karl-Henning Kalland, Inge Jonassen, Leroy Hood, Svein Andreas Haukaas, Sue Olsen, Laila Stordrange, Trond Hellem Bø, Hanne Puntervoll, Anne Margrete Øyan, Kari Rostad, Ole Johan Halvorsen
Purpose: The human SIM2 gene is located within the Down's syndrome critical region of chromosome 21 and encodes transcription factors involved in brain development and neuronal differentiation. SIM2 has been assigned a possible role in the pathogenes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8361f4686d4008dad244643f0e4f9e4a
https://doi.org/10.1158/1078-0432.c.6518694
https://doi.org/10.1158/1078-0432.c.6518694
Autor:
Lars Andreas Akslen, Karl-Henning Kalland, Inge Jonassen, Leroy Hood, Svein Andreas Haukaas, Sue Olsen, Laila Stordrange, Trond Hellem Bø, Hanne Puntervoll, Anne Margrete Øyan, Kari Rostad, Ole Johan Halvorsen
Supplementary Figure 2 from Increased Expression of SIM2-s Protein Is a Novel Marker of Aggressive Prostate Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06a3ed549b49a258d5366f141c9b7b87
https://doi.org/10.1158/1078-0432.22441761
https://doi.org/10.1158/1078-0432.22441761
Autor:
Signe Opdahl, Anna Mary Bofin, Borgny Ytterhus, Anne Irene Hagen, Johan Håkon Bjørngaard, Lars Andreas Akslen, Olav Anton Haugen, Monica Jernberg Engstrøm, Lars Johan Vatten, Marit Valla
Supplementary Table 3. Risk of death from breast cancer between diagnostic periods, for each molecular subtype 5 and 15 years after diagnosis (Cox regression analysis).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2096585946eb371af019aa273391ce0e
https://doi.org/10.1158/1055-9965.22437928
https://doi.org/10.1158/1055-9965.22437928
Autor:
Signe Opdahl, Anna Mary Bofin, Borgny Ytterhus, Anne Irene Hagen, Johan Håkon Bjørngaard, Lars Andreas Akslen, Olav Anton Haugen, Monica Jernberg Engstrøm, Lars Johan Vatten, Marit Valla
Supplementary Figure 2. Subtype-specific incidence rates according to age and year of birth. Blue lines: Women born before 1929. Red lines: Women born in 1929 or later. Dotted lines (red and blue) represent incidence rates of subtyped cases. Solid li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::177e23f78cf6f7016b3d986feee32432
https://doi.org/10.1158/1055-9965.22437943.v1
https://doi.org/10.1158/1055-9965.22437943.v1
Autor:
Signe Opdahl, Anna Mary Bofin, Borgny Ytterhus, Anne Irene Hagen, Johan Håkon Bjørngaard, Lars Andreas Akslen, Olav Anton Haugen, Monica Jernberg Engstrøm, Lars Johan Vatten, Marit Valla
Supplementary Figure 3. Cumulative incidence of death from breast cancer according to breast cancer subtypes. A: Women diagnosed before 1995 (Gray's test: p=0.0002). B: Women diagnosed in 1995 or later (Gray's test: p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e41ddb1f1a30169078f5438578501286
https://doi.org/10.1158/1055-9965.22437940
https://doi.org/10.1158/1055-9965.22437940
Autor:
Signe Opdahl, Anna Mary Bofin, Borgny Ytterhus, Anne Irene Hagen, Johan Håkon Bjørngaard, Lars Andreas Akslen, Olav Anton Haugen, Monica Jernberg Engstrøm, Lars Johan Vatten, Marit Valla
Supplementary Table 1. Characteristics of the study population used in estimations of breast cancer incidence.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13e40327a1810e607d91e22432416c08
https://doi.org/10.1158/1055-9965.22437934
https://doi.org/10.1158/1055-9965.22437934
Autor:
Signe Opdahl, Anna Mary Bofin, Borgny Ytterhus, Anne Irene Hagen, Johan Håkon Bjørngaard, Lars Andreas Akslen, Olav Anton Haugen, Monica Jernberg Engstrøm, Lars Johan Vatten, Marit Valla
Supplementary Table 2. Incidence rates and incidence rate ratios of breast cancer according to hormone and HER2 receptor status, age at diagnosis and year of birth. Observed and imputed estimates.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e9a7819ecd2eb10d829edfe0b076a03
https://doi.org/10.1158/1055-9965.22437931.v1
https://doi.org/10.1158/1055-9965.22437931.v1
Autor:
Signe Opdahl, Anna Mary Bofin, Borgny Ytterhus, Anne Irene Hagen, Johan Håkon Bjørngaard, Lars Andreas Akslen, Olav Anton Haugen, Monica Jernberg Engstrøm, Lars Johan Vatten, Marit Valla
Supplementary Table 5. Risk of death from breast cancer between diagnostic periods, for each breast cancer subtype 5 and 15 years after diagnosis (Cox regression analysis).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::674e892e2b683c74629077dcd0ad9484
https://doi.org/10.1158/1055-9965.22437925
https://doi.org/10.1158/1055-9965.22437925
Autor:
Signe Opdahl, Anna Mary Bofin, Borgny Ytterhus, Anne Irene Hagen, Johan Håkon Bjørngaard, Lars Andreas Akslen, Olav Anton Haugen, Monica Jernberg Engstrøm, Lars Johan Vatten, Marit Valla
Supplementary Figure legends.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::231f7edac60d6416a10384ef875bb9c1
https://doi.org/10.1158/1055-9965.22437937.v1
https://doi.org/10.1158/1055-9965.22437937.v1